ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 93 filers reported holding ADMA BIOLOGICS INC in Q2 2021. The put-call ratio across all filers is 5.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $184,000 | -79.0% | 115,100 | -76.9% | 0.12% | -84.0% |
| Q1 2021 | $876,000 | -49.1% | 497,842 | -43.6% | 0.72% | -9.9% |
| Q4 2020 | $1,722,000 | +34.5% | 883,214 | +65.0% | 0.80% | +30.7% |
| Q3 2020 | $1,280,000 | -66.4% | 535,324 | -58.8% | 0.61% | -62.7% |
| Q2 2020 | $3,807,000 | +6.4% | 1,299,300 | +4.6% | 1.63% | -2.3% |
| Q1 2020 | $3,579,000 | +46.7% | 1,242,700 | +126.6% | 1.67% | +23.7% |
| Q3 2019 | $2,440,000 | +239.4% | 548,409 | +195.3% | 1.35% | +272.7% |
| Q2 2019 | $719,000 | – | 185,721 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $13,240,000 | 11.29% |
| Stonepine Capital Management, LLC | 7,661,690 | $25,360,194 | 8.50% |
| Altium Capital Management LP | 2,870,000 | $9,499,700 | 5.27% |
| Caligan Partners LP | 1,662,613 | $5,503,249 | 3.84% |
| AWM Investment Company, Inc. | 6,015,000 | $19,909,650 | 2.69% |
| Perceptive Advisors | 11,900,255 | $39,389,844 | 1.16% |
| EAM Investors, LLC | 1,035,752 | $3,428,339 | 0.67% |
| OBERWEIS ASSET MANAGEMENT INC/ | 1,169,500 | $3,871,045 | 0.60% |
| Magnetar Financial LLC | 7,074,722 | $23,417,330 | 0.46% |
| Virtus ETF Advisers LLC | 83,925 | $277,792 | 0.15% |